Comparison of the effects of a new 32-Gauge×4-mm pen needle and a 32-Gauge×6-mm pen needle on glycemic control, safety, and patient ratings in japanese adults with diabetes

Diabetes Technology and Therapeutics

Volumn 14, Issue 12, 2012, Pages 1084-1090

  Miwa, Takashi ^a   Itoh, Rokuro ^a   Kobayashi, Takaaki ^a   Tanabe, Takashi ^a   Shikuma, Junpei ^a   Takahashi, Tomono ^a   Odawara, Masato ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED ALBUMIN; INSULIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLEEDING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS; FEMALE; GLYCEMIC CONTROL; HUMAN; INJECTION PAIN; INSULIN DEPENDENT DIABETES MELLITUS; JAPANESE; MALE; NEEDLE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT PREFERENCE; PATIENT SAFETY; PEN NEEDLE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; EQUIPMENT DESIGN; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRADERMAL; INSULIN; MALE; MIDDLE AGED; NEEDLES; PAIN MEASUREMENT; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 84871028505     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0170     Document Type: Article

References (20)

1. Korytkowski M, Bell D, Jacobsen C, Suwannasari R: A multicenter, randomized, open label, comparative, twoperiod crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/ syringe for insulin injections in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003;11:2836-2848.
2. Summers KH, Szeinbach SL, Lenox SM: Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther 2004;9:1498-1505.
3. Stockl K, Ory C, Vanderplas A, Nicklasson L, Lyness W, Cobden D, Chang E: An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe. Curr Med Res Opin 2007;23:133-146.
4. Rubin RR, Peyrot M: Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care 2004;27:2495-2497.
5. Bohannon NJ, Ohannesian JP, Burdan AL, Holcombe JH, Zagar A: Patient and physician satisfaction with the Humulin/Humalog pen, a new 3.0-mL prefilled pen device for insulin delivery. Clin Ther 2000;22:1049-1067.
6. Asche CV, Shane McWhorter L, Raparla S: Health economics and compliance of vials/syringes versus pen devices: A review of the evidence. Diabetes Technol Ther 2010;12(Suppl 1):S101YS108.
7. McKay M, Compion G, Lytzen L: A comparison of insulin injection needles on patients' perceptions of pain, handling, and acceptability: A randomized, open-label, crossover study in subjects with diabetes. Diabetes Technol Ther 2009;11: 195-201.
8. Schwartz S, Hassman D, Shelmet J, Sievers R, Weinstein R, Liang J, Lyness W: A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge •6mm needle versus a 29 gauge • 12.7mm needle in obese patients with diabetes mellitus. Clin Ther 2004;26:1663-1678.
9. Hirsch LJ, Gibney MA, Albanese J, Qu S, Kassler-Taub K, Klaff LJ, Bailey TS: Comparative glycemic control, safety and patient ratings for a new 4mm• 32G insulin pen needle in adults with diabetes. Curr Med Res Opin 2010;26:1531-1541.
10. Egekvist H, Bjerring P, Arendt-Nielsen L: Pain and mechanical injury of skin following mechanical needle insertions. Eur J Pain 1999;3:41-49.
11. Arendt-Nielsen L, Egekvist H, Bjerring P: Pain following controlled cutaneous insertion of needles with different diameters. Somatosens Mot Res 2006;23:37-43.
12. Kreugel G, Keers JC, Kerstens MN, Wolffenbuttel BH: Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes. Diabetes Technol Ther 2011;13: 737-741.
13. Ross SA, Jamal R, Leiter LA, Josse RG, Parkes JL, Qu S, Kerestan SP, Ginsberg BH: Evaluation of 8mm insulin pen needles in people with type 1 and type 2 diabetes. Pract Diabetes Int 1999;16:145-148.
14. Rondeau P, Bourdon E: The glycation of albumin: Ptructural and functional impacts. Biochimie 2011;93:645-658.
15. Yoshiuchi K, Matsuhisa M, Katakami N, Nakatani Y, Sakamoto K, Matsuoka T, Umayahara Y, Kosugi K, Kaneto H, Yamasaki Y, Hori M: Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Endocr J 2008;55:503-507.
16. Revill SI, Robinson JO, Rosen M, Hogg MIJ: The reliability of a linear analogue scale for evaluating pain. Anesthesia 1976;31:1191-1198.
17. Mantha S, Thisted R, Foss J, Ellis JE, Roizen MF: A proposal to use confidence intervals for visual analog scale data for pain measurement to determine clinical significance. Anesth Analg 1993;77:1041-1047.
18. Iwanaga M, Kamoi K: Patient perceptions of injection pain and anxiety: A comparison of NovoFine 32-gauge tip 6mm and Micro Fine Plus 31-gauge 5mm needles. Diabetes Technol Ther 2009;11:81-86.
19. Wittmann A, Kover B, Kralj N, Gasthaus K, Lerch H, Rommel M, Moses S, Hofmann F: Insulin leakage value in relation to pen needle length and administered dose after subcutaneous injection. Diabetes Technol Ther 2010;12:587-590.
20. Birkebaek NH, Solvig J, Hansen B, Jorgensen C, Smedegaard J, Christiansen JS: A 4-mm needle reduces the risk of intramuscular injections without increasing backflow to skin surface in lean diabetic children and adults. Diabetes Care 2008;31:e65.